Prostate Cancer
Showing NaN - NaN of 144
Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)
Recruiting
- Prostate Cancer
- Docetaxel 75 mg/m2
- +2 more
-
Gilbert, Arizona
- +52 more
Feb 2, 2023
Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))
Active, not recruiting
- Prostate Cancer
- ARN-509 (Phase 1)
- ARN-509 (Phase 2)
-
San Diego, California
- +14 more
Jan 17, 2023
Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)
Active, not recruiting
- Prostate Cancer
- Prostatic Neoplasm
- abiraterone acetate in combination with prednisone
-
Homewood, Alabama
- +44 more
Jan 17, 2023
Prostate Cancer Trial in United States (TAK-700, Bicalutamide)
Active, not recruiting
- Prostate Cancer
-
Birmingham, Alabama
- +559 more
Dec 5, 2022
Prostate Cancer Trial in Worldwide (Standard of Care)
Recruiting
- Prostate Cancer
- Standard of Care
-
Birmingham, Alabama
- +107 more
Aug 17, 2022
Prostate Cancer Trial in United States (Ceevra Reveal)
Active, not recruiting
- Prostate Cancer
- Ceevra Reveal
-
Los Angeles, California
- +5 more
Jul 19, 2022
Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- SRF617
- +2 more
-
Miami, Florida
- +6 more
Jun 13, 2022
Cushing's Disease, Acromegaly, Neuroendocrine Tumors Trial in Worldwide (Pasireotide, Cabergoline)
Active, not recruiting
- Cushing's Disease
- +8 more
-
La Jolla, California
- +93 more
May 19, 2022
Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,
Completed
- Prostate Adenocarcinoma
- +2 more
- Enzalutamide
- +3 more
-
Baltimore, Maryland
- +3 more
Mar 30, 2022
Prostate Cancer, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide, CC-115)
Active, not recruiting
- Prostate Cancer
- Castration Resistant Prostate Cancer
-
San Francisco, California
- +4 more
Mar 18, 2022
Prostate Cancer Trial in United States (Clinical Order Check, Academic Detailing, Audit and Feedback)
Active, not recruiting
- Prostate Cancer
- Clinical Order Check
- +2 more
-
Palo Alto, California
- +10 more
Mar 7, 2022
Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples
Enrolling by invitation
- Breast Cancer
- +4 more
-
Seattle, WashingtonGBC
Mar 14, 2022
Prostate Cancer Trial in United States (NanoTherm Ablation)
Recruiting
- Prostate Cancer
- NanoTherm Ablation
-
Tampa, Florida
- +3 more
Mar 4, 2022
Prostate Cancer Trial in United States (Proton Beam Therapy, Intensity Modulated Radiation Therapy)
Recruiting
- Prostate Cancer
- Proton Beam Therapy
- Intensity Modulated Radiation Therapy
-
Jacksonville, Florida
- +12 more
Oct 29, 2021
Metastatic Cancer, Prostate Cancer Trial in United States (atrasentan HCl, docetaxel, prednisone)
Completed
- Metastatic Cancer
- Prostate Cancer
- atrasentan hydrochloride
- +3 more
-
Mobile, Alabama
- +553 more
Oct 8, 2021
Cesium-131 in Combination With External Beam Radiation for
Withdrawn
- Prostate Cancer
-
Phoenix, Arizona
- +8 more
Apr 14, 2021
Prostate Cancer Trial in Argentina, United States (Sagopilone (ZK 219477) + prednisone)
Completed
- Prostate Cancer
- Sagopilone (ZK 219477) + prednisone
-
Fountain Valley, California
- +16 more
Apr 6, 2021
Prostate Cancer Trial in United States (GTx-758 125 mg, GTx-758 250 mg)
Completed
- Prostate Cancer
- GTx-758 125 mg
- GTx-758 250 mg
-
Burbank, California
- +25 more
Mar 3, 2021
Prostate Cancer, Prostatic Cancer, Prostate Tumors Trial in United States (CyberKnife Stereotactic Radiosurgery)
Active, not recruiting
- Prostate Cancer
- +4 more
- CyberKnife Stereotactic Radiosurgery
-
Phoenix, Arizona
- +22 more
Mar 3, 2021
Prostate Cancer Trial in New Brunswick, Seattle, Madison (pTVG-AR, gm-csf)
Completed
- Prostate Cancer
- pTVG-AR
- gm-csf
-
New Brunswick, New Jersey
- +2 more
Feb 2, 2021